Kdm6a-CNN1 axis orchestrates epigenetic control of trauma-induced spinal cord microvascular endothelial cell senescence to balance neuroinflammation for improved neurological repair

• Published in: Bone Research Vol. 12; no. 1; p. 19
• Main Authors: Li, Chengjun, Qin, Tian, Zhao, Jinyun, Jin, Yuxin, Qin, Yiming, He, Rundong, Wu, Tianding, Duan, Chunyue, Jiang, Liyuan, Yuan, Feifei, Lu, Hongbin, Cao, Yong, Hu, Jianzhong
• Format: Journal Article
• Language: English
• Published: China Springer Nature B.V 25-03-2024; Nature Publishing Group UK; Nature Publishing Group
• Subjects: Cellular Senescence - genetics; Endothelial Cells; Epigenesis, Genetic; Epigenetics; Humans; Neuroinflammatory Diseases; Senescence; Spinal cord; Spinal Cord Injuries - genetics; Trauma
• ISSN: 2095-4700; 2095-6231
• DOI: 10.1038/s41413-024-00323-x

Cellular senescence assumes pivotal roles in various diseases through the secretion of proinflammatory factors. Despite extensive investigations into vascular senescence associated with aging and degenerative diseases, the molecular mechanisms governing microvascular endothelial cell senescence induced by traumatic stress, particularly its involvement in senescence-induced inflammation, remain insufficiently elucidated. In this study, we present a comprehensive demonstration and characterization of microvascular endothelial cell senescence induced by spinal cord injury (SCI). Lysine demethylase 6A (Kdm6a), commonly known as UTX, emerges as a crucial regulator of cell senescence in injured spinal cord microvascular endothelial cells (SCMECs). Upregulation of UTX induces senescence in SCMECs, leading to an amplified release of proinflammatory factors, specifically the senescence-associated secretory phenotype (SASP) components, thereby modulating the inflammatory microenvironment. Conversely, the deletion of UTX in endothelial cells shields SCMECs against senescence, mitigates the release of proinflammatory SASP factors, and promotes neurological functional recovery after SCI. UTX forms an epigenetic regulatory axis by binding to calponin 1 (CNN1), orchestrating trauma-induced SCMECs senescence and SASP secretion, thereby influencing neuroinflammation and neurological functional repair. Furthermore, local delivery of a senolytic drug reduces senescent SCMECs and suppresses proinflammatory SASP secretion, reinstating a local regenerative microenvironment and enhancing functional repair after SCI. In conclusion, targeting the UTX-CNN1 epigenetic axis to prevent trauma-induced SCMECs senescence holds the potential to inhibit SASP secretion, alleviate neuroinflammation, and provide a novel treatment strategy for SCI repair.